Sun. Jul 14th, 2024

CarePoint Health Unveils Advanced Test for Early Detection of Multiple Cancers

By Vaseline Jun10,2024

Listen to this article

CarePoint Health patients in Hudson County will soon have access to an innovative test for early detection of multiple cancers through a new partnership.

The health care system announced its partnership with GRAIL LLC on June 6. The California-based biotechnology company focuses on the early detection of cancer, including with its Galleri multi-cancer early detection (MCED) test.

The organizations say offering the Galleri test will allow CarePoint to improve its comprehensive cancer care. After a positive test, the healthcare system will use the technology to support patients and healthcare providers throughout the diagnostic journey.

Available only by prescription, Galleri is the first clinically validated MCED test of its kind that can detect a shared cancer signal for more than 50 types of cancer using a simple blood draw. GRAIL says this “revolutionary blood-based approach” is intended to be used as an adjunct to recommended single cancer screenings.

Eligible CarePoint patients must:

  • Be established patients of one of CarePoint Health’s primary/specialty care practices;
  • Have an increased risk of cancer, such as people aged 50 or older;
  • Not currently pregnant;
  • Not receiving active cancer treatment or having completed cancer treatment at least five years ago.

“As we strive to provide unparalleled care to the people of Hudson County, we are proud to introduce state-of-the-art early detection for multiple cancers to our hospital,” said Dr. John Rimmer, Chief Medical Officer of CarePoint Health System. “CarePoint’s mission to embrace innovation is not just about treating disease, but about strengthening prevention and saving lives as soon as possible.”

“We have an opportunity to shift the cancer screening paradigm with early detection tests for multiple cancers, to screen for a ‘fingerprint’ of the deadliest cancers before they become symptomatic, including those that currently have no recommended screening tests,” said Dr. Jeffrey Venstrom, chief medical officer at GRAIL.

As far as modern medicine goes, this is our best chance to increase our chances of beating cancer early.
Justin Drew ZorgPoint

The companies note that the recommended screenings cover only five types of cancer. Meanwhile, according to the American Cancer Society, more than 600,000 people nationally die from cancer every year – mostly due to late-stage diagnoses. For approximately 70% of cancer deaths, there is no recommended screening for early detection.

By the numbers:

In the U.S, More than 600,000 People die from cancer every year.
– SOURCE: American Cancer Society

“By offering the Galleri test to Hudson County patients, CarePoint Health is giving patients the best opportunity to early screen and ultimately diagnose many types of cancer,” Venstrom said.

He added that GRAIL would like to share in their commitment to better patient care.

CarePoint officials echoed that sentiment.

“We are proud to partner with GRAIL to bring this innovative testing service to the Hudson County community,” said Rimmer.

“As far as modern medicine goes, this is our best chance to improve our chances of beating cancer early,” said Justin Drew, CarePoint chief of staff and vice president of marketing and strategy. “And we are so proud to offer this service to our patients.”

Related Post